Congress Materials – International Dermatology Outcome Measures (IDEOM 2025)
2025 International Dermatology Outcome Measures | Jun 27-28 | Washington, DC
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23–Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-blind, Placebo-Controlled ICONIC-LEAD Trial
Robert Bissonnette, Jennifer Soung, Adelaide Hebert, Andrew E. Pink, Andreas Pinter, Yuling Shi, Megan Miller, Joseph Cafone, Jing Zhi (Gigi) Jiang, Sarah Ofori, Cynthia DeKlotz, Mark G. Lebwohl
This document will be available on June 27 2025
SPECTREM: Guselkumab Efficacy Across Multiple High-Impact Sites in Participants With Low BSA, Moderate Psoriasis
Harrison Nguyen, Nicole Seminara, Henry Yu, Theodore Alkousakis, Olivia Choi, Katelyn Rowland, Daphne Chan, Jenny Jeyarajah, Safiya Ransome, Angela Moore, Lorne Albrecht
This document will be available on June 27 2025
VISIBLE Cohort B: Guselkumab Demonstrated Scalp Clearance and Improved Health-Related Quality of Life Through Week 48 in Participants With Moderate-to-Severe Scalp Psoriasis Across All Skin Tones
Amy McMichael, Tina Bhutani, Stacy Smith, Theodore Alkousakis, Olivia Choi, Daphne Chan, Tony Ma, Sarah Ofori, Ross Radusky, Jensen Yeung, George Han, Susan C. Taylor
This document will be available on June 27 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.